Mika Aoyagi-Scharber is an accomplished professional in the biopharmaceutical industry, currently serving as Vice President, Translational Research, Program & Portfolio Management at Ultragenyx since April 2021, having previously held the position of Executive Director in the same area. Prior to joining Ultragenyx, Mika Aoyagi-Scharber spent nearly 14 years at BioMarin Pharmaceutical Inc., progressing through various roles including Executive Director, Senior Director, and Director of Scientific Strategy & Discovery Portfolio. Early career experience includes serving as a Postdoctoral Associate at Burnham Institute for Medical Research and a Postdoctoral Fellow at The Scripps Research Institute. Educational qualifications include a Ph.D. from Scripps Research and a B.S. in Biochemistry from the University of Minnesota.
This person is not in any teams
This person is not in any offices